Edition:
United Kingdom

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

6.22USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$6.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
97,559
52-wk High
$8.26
52-wk Low
$3.30

Chart for

About

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $244.56
Shares Outstanding(Mil.): 37.28
Dividend: --
Yield (%): --

Financials

  OCUL.OQ Industry Sector
P/E (TTM): -- 41.57 33.15
EPS (TTM): -2.02 -- --
ROI: -83.98 14.53 13.23
ROE: -108.11 17.68 15.27

BRIEF-Ocular Therapeutix Reports Q1 Loss Per Share $0.40

* OCULAR THERAPEUTIX™ REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND BUSINESS UPDATE

08 May 2018

BRIEF-Ocular Therapeutix Reports Q4 Loss Per Share $0.44

* OCULAR THERAPEUTIX™ REPORTS FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND BUSINESS UPDATE

08 Mar 2018

BRIEF-Summer Road Reports 8.4 Pct Passive Stake In Ocular Therapeutix

* SUMMER ROAD LLC REPORTS 8.4 PERCENT PASSIVE STAKE IN OCULAR THERAPEUTIX INC AS OF JANUARY 29, 2018 - SEC FILING‍​ Source text: (http://bit.ly/2BjW1c4) Further company coverage:

08 Feb 2018

BRIEF-Ocular TherapeutixTM Announces Public Offering Of 6.50 Mln Common Shares

* OCULAR THERAPEUTIXTM ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK

25 Jan 2018

BRIEF-Ocular Therapeutix Announces Proposed Public Offering Of Common Stock

* OCULAR THERAPEUTIX™ ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

24 Jan 2018

Earnings vs. Estimates